Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 17 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
Silvercorp Metals Inc. (NYSE-A: SVM) (TSX: SVM) Updated Resource Estimate for Condor Project Highlights High-Grade Underground Potential
Total indicated underground mineral resources of 3.17 million tonnes at Camp and Los Cuyes deposits,…
-
Dynamic Global Events Presents: The 6th Clinical Trial Agreements Summit
Dynamic Global Events (“DGE”) is proud to announce the 6th Clinical Trial Agreements Summit taking…
-
QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E,…